Polygenic risk for type 2 diabetes, lifestyle, metabolic health, and cardiovascular disease: a prospective UK Biobank study

Abstract Background Few studies have examined associations between genetic risk for type 2 diabetes (T2D), lifestyle, clinical risk factors, and cardiovascular disease (CVD). We aimed to investigate the association of and potential interactions among genetic risk for T2D, lifestyle behavior, and met...

Full description

Bibliographic Details
Main Authors: Jae-Seung Yun, Sang-Hyuk Jung, Manu Shivakumar, Brenda Xiao, Amit V. Khera, Hong-Hee Won, Dokyoon Kim
Format: Article
Language:English
Published: BMC 2022-07-01
Series:Cardiovascular Diabetology
Subjects:
Online Access:https://doi.org/10.1186/s12933-022-01560-2
_version_ 1828747133053829120
author Jae-Seung Yun
Sang-Hyuk Jung
Manu Shivakumar
Brenda Xiao
Amit V. Khera
Hong-Hee Won
Dokyoon Kim
author_facet Jae-Seung Yun
Sang-Hyuk Jung
Manu Shivakumar
Brenda Xiao
Amit V. Khera
Hong-Hee Won
Dokyoon Kim
author_sort Jae-Seung Yun
collection DOAJ
description Abstract Background Few studies have examined associations between genetic risk for type 2 diabetes (T2D), lifestyle, clinical risk factors, and cardiovascular disease (CVD). We aimed to investigate the association of and potential interactions among genetic risk for T2D, lifestyle behavior, and metabolic risk factors with CVD. Methods A total of 345,217 unrelated participants of white British descent were included in analyses. Genetic risk for T2D was estimated as a genome-wide polygenic risk score constructed from > 6 million genetic variants. A favorable lifestyle was defined in terms of four modifiable lifestyle components, and metabolic health status was determined according to the presence of metabolic syndrome components. Results During a median follow-up of 8.9 years, 21,865 CVD cases (6.3%) were identified. Compared with the low genetic risk group, participants at high genetic risk for T2D had higher rates of overall CVD events, CVD subtypes (coronary artery disease, peripheral artery disease, heart failure, and atrial fibrillation/flutter), and CVD mortality. Individuals at very high genetic risk for T2D had a 35% higher risk of CVD than those with low genetic risk (HR 1.35 [95% CI 1.19 to 1.53]). A significant gradient of increased CVD risk was observed across genetic risk, lifestyle, and metabolic health status (P for trend > 0.001). Those with favorable lifestyle and metabolically healthy status had significantly reduced risk of CVD events regardless of T2D genetic risk. This risk reduction was more apparent in young participants (≤ 50 years). Conclusions Genetic risk for T2D was associated with increased risks of overall CVD, various CVD subtypes, and fatal CVD. Engaging in a healthy lifestyle and maintaining metabolic health may reduce subsequent risk of CVD regardless of genetic risk for T2D.
first_indexed 2024-04-14T04:37:06Z
format Article
id doaj.art-73e788d15b10429dbda623e219670bd5
institution Directory Open Access Journal
issn 1475-2840
language English
last_indexed 2024-04-14T04:37:06Z
publishDate 2022-07-01
publisher BMC
record_format Article
series Cardiovascular Diabetology
spelling doaj.art-73e788d15b10429dbda623e219670bd52022-12-22T02:11:49ZengBMCCardiovascular Diabetology1475-28402022-07-0121111110.1186/s12933-022-01560-2Polygenic risk for type 2 diabetes, lifestyle, metabolic health, and cardiovascular disease: a prospective UK Biobank studyJae-Seung Yun0Sang-Hyuk Jung1Manu Shivakumar2Brenda Xiao3Amit V. Khera4Hong-Hee Won5Dokyoon Kim6Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of PennsylvaniaDepartment of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of PennsylvaniaDepartment of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of PennsylvaniaDepartment of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of PennsylvaniaCenter for Genomic Medicine, Massachusetts General HospitalSamsung Advanced Institute for Health Sciences and Technology (SAIHST), Samsung Medical Center, Sungkyunkwan UniversityDepartment of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of PennsylvaniaAbstract Background Few studies have examined associations between genetic risk for type 2 diabetes (T2D), lifestyle, clinical risk factors, and cardiovascular disease (CVD). We aimed to investigate the association of and potential interactions among genetic risk for T2D, lifestyle behavior, and metabolic risk factors with CVD. Methods A total of 345,217 unrelated participants of white British descent were included in analyses. Genetic risk for T2D was estimated as a genome-wide polygenic risk score constructed from > 6 million genetic variants. A favorable lifestyle was defined in terms of four modifiable lifestyle components, and metabolic health status was determined according to the presence of metabolic syndrome components. Results During a median follow-up of 8.9 years, 21,865 CVD cases (6.3%) were identified. Compared with the low genetic risk group, participants at high genetic risk for T2D had higher rates of overall CVD events, CVD subtypes (coronary artery disease, peripheral artery disease, heart failure, and atrial fibrillation/flutter), and CVD mortality. Individuals at very high genetic risk for T2D had a 35% higher risk of CVD than those with low genetic risk (HR 1.35 [95% CI 1.19 to 1.53]). A significant gradient of increased CVD risk was observed across genetic risk, lifestyle, and metabolic health status (P for trend > 0.001). Those with favorable lifestyle and metabolically healthy status had significantly reduced risk of CVD events regardless of T2D genetic risk. This risk reduction was more apparent in young participants (≤ 50 years). Conclusions Genetic risk for T2D was associated with increased risks of overall CVD, various CVD subtypes, and fatal CVD. Engaging in a healthy lifestyle and maintaining metabolic health may reduce subsequent risk of CVD regardless of genetic risk for T2D.https://doi.org/10.1186/s12933-022-01560-2Polygenic risk scoreLifestyleMetabolic healthCardiovascular diseaseType 2 diabetes
spellingShingle Jae-Seung Yun
Sang-Hyuk Jung
Manu Shivakumar
Brenda Xiao
Amit V. Khera
Hong-Hee Won
Dokyoon Kim
Polygenic risk for type 2 diabetes, lifestyle, metabolic health, and cardiovascular disease: a prospective UK Biobank study
Cardiovascular Diabetology
Polygenic risk score
Lifestyle
Metabolic health
Cardiovascular disease
Type 2 diabetes
title Polygenic risk for type 2 diabetes, lifestyle, metabolic health, and cardiovascular disease: a prospective UK Biobank study
title_full Polygenic risk for type 2 diabetes, lifestyle, metabolic health, and cardiovascular disease: a prospective UK Biobank study
title_fullStr Polygenic risk for type 2 diabetes, lifestyle, metabolic health, and cardiovascular disease: a prospective UK Biobank study
title_full_unstemmed Polygenic risk for type 2 diabetes, lifestyle, metabolic health, and cardiovascular disease: a prospective UK Biobank study
title_short Polygenic risk for type 2 diabetes, lifestyle, metabolic health, and cardiovascular disease: a prospective UK Biobank study
title_sort polygenic risk for type 2 diabetes lifestyle metabolic health and cardiovascular disease a prospective uk biobank study
topic Polygenic risk score
Lifestyle
Metabolic health
Cardiovascular disease
Type 2 diabetes
url https://doi.org/10.1186/s12933-022-01560-2
work_keys_str_mv AT jaeseungyun polygenicriskfortype2diabeteslifestylemetabolichealthandcardiovasculardiseaseaprospectiveukbiobankstudy
AT sanghyukjung polygenicriskfortype2diabeteslifestylemetabolichealthandcardiovasculardiseaseaprospectiveukbiobankstudy
AT manushivakumar polygenicriskfortype2diabeteslifestylemetabolichealthandcardiovasculardiseaseaprospectiveukbiobankstudy
AT brendaxiao polygenicriskfortype2diabeteslifestylemetabolichealthandcardiovasculardiseaseaprospectiveukbiobankstudy
AT amitvkhera polygenicriskfortype2diabeteslifestylemetabolichealthandcardiovasculardiseaseaprospectiveukbiobankstudy
AT hongheewon polygenicriskfortype2diabeteslifestylemetabolichealthandcardiovasculardiseaseaprospectiveukbiobankstudy
AT dokyoonkim polygenicriskfortype2diabeteslifestylemetabolichealthandcardiovasculardiseaseaprospectiveukbiobankstudy